MAPK3 and diabetes mellitus: In conclusion, this study has highlighted that diabetes and/or high glucose induced ErbB2 and downstream signaling pathways involving ROCK, p-38 MAP kinase, ERK1/2, eNOS, and IkB-α could be effectively blocked by Ang-(1–7) in vitro and in vivo.